We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLK icon
351
Blackrock
BLK
$170B
$4.37M 0.06%
10,215
+1,167
+13% +$490K
BKR icon
352
Baker Hughes
BKR
$58B
$4.36M 0.06%
157,136
+49,805
+46% +$1.26M
ZTS icon
353
Zoetis
ZTS
$32.5B
$4.25M 0.05%
42,213
-7,421
-15% -$674K
BSX icon
354
Boston Scientific
BSX
$68.5B
$4.23M 0.05%
110,093
+3,899
+4% +$149K
KEY icon
355
KeyCorp
KEY
$24.3B
$4.17M 0.05%
264,508
+53,182
+25% +$887K
TVPT
356
DELISTED
Travelport Worldwide Limited
TVPT
$4.16M 0.05%
+264,697
New +$4.15M
GL icon
357
Globe Life
GL
$13.9B
$4.14M 0.05%
18,574
+3,427
+23% +$280K
AVB icon
358
AvalonBay Communities
AVB
$27.2B
$4.13M 0.05%
11,603
+577
+5% +$110K
CCI icon
359
Crown Castle
CCI
$33.1B
$4.11M 0.05%
32,100
+962
+3% +$113K
NFG icon
360
National Fuel Gas
NFG
$7.73B
$4.06M 0.05%
66,621
+24,897
+60% +$1.45M
YUM icon
361
Yum! Brands
YUM
$41.4B
$4.05M 0.05%
28,549
+1,146
+4% +$109K
RL icon
362
Ralph Lauren
RL
$22.5B
$4.04M 0.05%
31,130
+26,943
+643% +$3.21M
IP icon
363
International Paper
IP
$23.3B
$4.01M 0.05%
91,613
+18,615
+26% +$807K
BAX icon
364
Baxter International
BAX
$12.6B
$3.98M 0.05%
48,892
-21
-0% -$1.53K
HUBB icon
365
Hubbell
HUBB
$25.6B
$3.96M 0.05%
33,532
-5,660
-14% -$640K
DGX icon
366
Quest Diagnostics
DGX
$26B
$3.86M 0.05%
31,978
+9,705
+44% +$841K
RVTY icon
367
Revvity
RVTY
$12.4B
$3.85M 0.05%
40,000
– –
MDCO
368
DELISTED
Medicines Co
MDCO
$3.81M 0.05%
136,500
– –
CNC icon
369
Centene
CNC
$31.6B
$3.81M 0.05%
71,683
+45,739
+176% +$2.78M
HPE icon
370
Hewlett Packard
HPE
$60.4B
$3.8M 0.05%
246,079
-20,823
-8% -$321K
RVNC
371
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.73M 0.05%
237,000
– –
NCLH icon
372
Norwegian Cruise Line
NCLH
$9.74B
$3.72M 0.05%
67,717
+56,008
+478% +$2.89M
SWK icon
373
Stanley Black & Decker
SWK
$14.6B
$3.71M 0.05%
27,242
-9,227
-25% -$1.2M
PH icon
374
Parker-Hannifin
PH
$125B
$3.7M 0.05%
21,577
+1,810
+9% +$300K
ODFL icon
375
Old Dominion Freight Line
ODFL
$47.1B
$3.7M 0.05%
+76,803
New +$3.59M
13 14
15
16 17

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.